TransMedics Gr Q4 EPS $0.12 Beats $(0.03) Estimate, Sales $81.17M Beat $68.51M Estimate
Portfolio Pulse from Benzinga Newsdesk
TransMedics Gr (NASDAQ:TMDX) reported Q4 earnings of $0.12 per share, surpassing the $(0.03) estimate, marking a 157.14% increase from last year. Sales reached $81.17M, beating the $68.51M estimate, a 158.72% increase from the previous year.
February 26, 2024 | 9:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TransMedics Gr reported a significant beat on both earnings and sales estimates for Q4, with EPS at $0.12 against a $(0.03) estimate and sales of $81.17M against a $68.51M estimate.
The significant beat on both earnings per share and sales estimates for Q4 indicates strong financial performance and operational efficiency. This outperformance, especially when compared to the same period last year, is likely to positively influence investor sentiment and potentially lead to a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100